All content for Cardio Ed is the property of The Cardio Ed Podcast and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Let's talk about contemporary issues in cardiology.
Let's discuss and learn together.
Join me in this quest for knowledge in cardiology.
CHIEF HF Trial. CANAGLIFLOZIN in HEART FAILURE. AHA 2021
Cardio Ed
4 minutes 14 seconds
3 years ago
CHIEF HF Trial. CANAGLIFLOZIN in HEART FAILURE. AHA 2021
CHIEF HF Trial was recently presented at the AHA 2021 meeting. It tested an #SGLT2Inhibitor #CANAGLIFLOZIN in #HEARTFAILURE.
CHIEF HF Trial or CANAGLIFLOZIN in HEART FAILURE which was recently presented at AHA 2021 is yet to be published.
If you were searching about CHIEF HF Trial or role of CANAGLIFLOZIN in HEART FAILURE you can find it in this video. The authors first presented its results in AHA 2021.
Cardio Ed
Let's talk about contemporary issues in cardiology.
Let's discuss and learn together.
Join me in this quest for knowledge in cardiology.
